Cita APA (7a ed.)

JD, S., & IP, S. (2019). Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgery. Dove Medical Press.

Cita Chicago Style (17a ed.)

JD, Sheppard, y Singh IP. Real World Use of Loteprednol Etabonate Ophthalmic Gel 0.5% in Cases Representative of Comorbid Pathologies Responding to Minimally Invasive Glaucoma Surgery. Dove Medical Press, 2019.

Cita MLA (8a ed.)

JD, Sheppard, y Singh IP. Real World Use of Loteprednol Etabonate Ophthalmic Gel 0.5% in Cases Representative of Comorbid Pathologies Responding to Minimally Invasive Glaucoma Surgery. Dove Medical Press, 2019.